ArticleArthritis & rheumatology (Hoboken, N.J.)2022

Long-term risk of cancer development among anti-Th/To antibody-positive systemic sclerosis patients: comment on the article by Mecoli et al.

Yuta Yamashita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.